Table 5.
Minimum inhibitory concentrations (MICs) and susceptibilities: Case 9–14.
| MIC (µg/mL) | Case 9 [6] | Case 10 [11] | Case 11 [10] | Case 12 [9] | Case 14 [4] |
|---|---|---|---|---|---|
| Amikacin | – | S (0.5) | – | S | – |
| Ampicillin | NA (1) | NA | – | – | NA |
| Ampicillin/Sulbactam | – | – | R (≥32) | – | NA |
| Aztreonam | – | – | – | R | – |
| Cefazolin | – | – | NA (32) | – | – |
| Cefepime | – | – | S (≤1) | – | – |
| Ceftazidime | – | S (1) | S (2) | S | S |
| Ceftriaxone | – | S (4) | S (8) | R | – |
| Cephalothin | – | NA | – | – | – |
| Ciprofloxacin | S (0.023) | S (0.125) | S (≤0.25) | S | S |
| Colistin | – | S | – | – | – |
| Gentamicin | S (2) | S (0.25) | S (≤1) | S | – |
| Meropenem | S (0.125) | – | – | – | – |
| Netilmicin | – | S | – | – | – |
| Ofloxacin | – | – | – | S | – |
| Pefloxacin | – | S | – | – | – |
| Piperacillin | – | S (0.62) | – | S | – |
| Piperacillin/Tazobactam | – | – | S (≤4) | – | S |
| SMZ-TMP | – | S (≤0.25/4.75) | – | – | S |
| Tobramycin | – | – | – | S | – |